PEDS Advance Access originally published online on August 2, 2009
Protein Engineering Design and Selection 2009 22(11):649-654; doi:10.1093/protein/gzp048
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression and purification of active recombinant equine lysozyme in Escherichia coli
asait
1,4
yt
1
nas
etkus2
kys11Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Mokslininku 12, Vilnius LT-08662, Lithuania 2 Semiconductor Physics Institute, A. Gostauto 11, Vilnius LT-01108, Lithuania 3Department of Medical Biochemistry and Biophysics, Umea University SE-90187, Umea, Sweden
4 To whom correspondence should be addressed. E-mail: vidac{at}bchi.lt
Equine lysozyme (EL) is a calcium (Ca)-binding lysozyme and is an intermediary link between non-Ca-binding C-type lysozyme and
-lactalbumin. The feature of lysozymes to assemble into the fibrils has recently gained considerable attention for the investigation of the functional properties of these proteins. To study the structural and functional properties of EL, a synthetic gene was cloned and EL was overexpressed in Escherichia coli as a fused protein. The His-tagged recombinant EL was accumulated as inclusion bodies. Up to 50 mg/l of the recombinant EL could be achieved after purification by Ni2+ affinity chromatography, refolding in the presence of arginine, CM-Sepharose column purification following TEV protease cleavage. The purified protein was functionally active, as determined by the lysozyme activity, proving the proper folding of protein. The purified lysozyme was used for the oligomerisation studies. The protein formed amyloid fibrils during incubation in acidic pH and elevated temperature. The recombinant EL forms two types of fibrils: ring shaped and linear, similar to the native EL.
Keywords: amyloid fibrils/equine lysozyme/heterologous expression/inclusion body
Received June 4, 2009; revised June 4, 2009; accepted July 8, 2009.